Stepwise management of asthma. Issue 1 (3rd September 2015)

• Record Type: Journal Article
• Authors: Khalid, Ayesha N.
• Is Part Of: International forum of allergy & rhinology. Volume 5:Issue 1(2015:Jan.)
• Page Start: S41
• Page End: S44
• Publication Date: 2015-09-03
• Subjects: 617.51005
• DOI: 10.1002/alr.21606
• Languages: English
• ISSNs: 2042-6976

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="alr21606-sec-0010" sec-type="section"> <title>Background</title> <p>Stepwise management of asthma remains an area of evolving research. Asthma is one of the most expensive chronic diseases in the United States; stepwise management is an important area of focus, with several recent guidelines recommending management.</p> </sec> <sec id="alr21606-sec-0020" sec-type="section"> <title>Methods</title> <p>This is a review of published English language literature, focusing on management guidelines for asthma in adult and pediatric patients.</p> </sec> <sec id="alr21606-sec-0030" sec-type="section"> <title>Results</title> <p>Asthma is a chronic disease whose assessment of severity allows for therapeutic goals to match the impairment noted. Good evidence exists to aid risk reduction, leading to decreased emergency room visits, preventing loss of lung function in adults and lung growth in children, and optimizing pharmacotherapy with reduced side effects profile.</p> </sec> <sec id="alr21606-sec-0040" sec-type="section"> <title>Conclusion</title> <p>Recent asthma management guidelines incorporate 4 components of asthma care including: monitoring of severity, patient education, controlling external triggers, and medications, including recent attention to medication adherence. Asthma is an expensive chronic disease with preventive measures leading to reduced healthcare costs. Future targeted cytokine therapy to decrease serum and blood eosinophils may become an integral part of asthma management.</p> </sec> </abstract>